INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2014

Gut microbiota dysbiosis, including reduced levels of butyrate-producing bacteria, is linked to type 2 diabetes and metabolic alterations.

This review discusses the relationship between gut microbiota, obesity, and type 2 diabetes (T2D). Human metagenome-wide association studies show significant correlations between specific intestinal bacteria, bacterial genes, and metabolic pathways with T2D. Notably, concentrations of butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii were lower in T2D subjects. Additionally, gut-derived endotoxaemia is observed in metabolic syndrome and T2D, and specific bacteria like Akkermansia muciniphila may be decreased in diabetes and exert antidiabetic effects in murine models.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Human and animal studies discussing gut microbiota and diabetes
What was measured
Associations between gut microbiota, dysbiosis, and type 2 diabetes

THE PAPER

Microbiota and diabetes: an evolving relationship.

Tilg H, Moschen AR. Gut, 2014.

PubMed 24833634 ↗DOI 10.1136/gutjnl-2014-306928 ↗

Heart & arteriesDiabetes & blood sugarGut & microbiomeWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.